Avecho Biotechnology Limited Stock: price and insider trades · Australia
Avecho Biotechnology Limited: what insiders have been doing
Avecho Biotechnology Limited belongs to the Health Care sector. Filings by its managers are published through ASX. From 23 October 2025 to 23 October 2026, the disclosure feed for Avecho Biotechnology Limited logged 2 filings by 2 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Compared with its exchange (1,594 companies, median 4 filings), a count of 2 filings is below the norm.
Insider buying of Avecho Biotechnology Limited has been absent for the past year.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ShareASXASX:2924-03095699-3A694398
- 0100.0% of flowShareASXASX:2924-03089743-3A693240
2 of 2 declarations
About Avecho Biotechnology Limited
AVE is a company listed on the XASX market. It operates in the financial sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
